Quarterly Consolidated Statement Of Cash Flows

DAIKEN MEDICAL CO.,LTD - Filing #7332058

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,999,041,000 JPY
1,372,392,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-4,903,000 JPY
-3,762,000 JPY
Income taxes paid
-438,637,000 JPY
-379,472,000 JPY
Net cash provided by (used in) operating activities
1,555,500,000 JPY
989,156,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-161,900,000 JPY
-197,949,000 JPY
Net cash provided by (used in) investing activities
-168,767,000 JPY
-210,526,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
400,000,000 JPY
Repayments of long-term borrowings
-659,972,000 JPY
-604,492,000 JPY
Purchase of treasury shares
-1,000 JPY
0 JPY
Dividends paid
-573,955,000 JPY
-565,320,000 JPY
Net cash provided by (used in) financing activities
-1,163,804,000 JPY
-781,007,000 JPY
Net increase (decrease) in cash and cash equivalents
222,929,000 JPY
-2,377,000 JPY
Cash and cash equivalents
2,739,141,000 JPY
2,516,212,000 JPY
2,518,589,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.